ConductScience.org, home

Paper41799211

In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis.

Kuang H and 11 others. Theranostics, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis. Papers, record 41799211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41799211

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis.
PubMed
Journal
Theranostics
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuang HHuang
2Lin CXCai-Xia
3Huang JJing
4Li WXWen-Xuan
5Zhu YGYu-Ge
6Jiang NNan
7Li ZZhong
8Li NNan
9Li PPing
10Jia XYXiao-Yu
11Cui ZZhao
12Zhao MHMing-Hui

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
T-Lymphocytes, RegulatoryMajor topic
Interleukin-2Major topic
GlomerulonephritisMajor topic
Autoimmune DiseasesMajor topic
Animals
Humans
Macaca fascicularis
Mice
Disease Models, Animal
Female
Recombinant Fusion Proteins
Lymphocyte Activation

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134306974In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.Adv Sci (Weinh)2021https://conductscience.org/library/papers/34306974PubMed
218510923Regulatory T cells and immune tolerance.Cell2008https://conductscience.org/library/papers/18510923PubMed
337598856Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease.Kidney Int2023https://conductscience.org/library/papers/37598856PubMed
434593809Membranous nephropathy.Nat Rev Dis Primers2021https://conductscience.org/library/papers/34593809PubMed
532843568Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms.Diabetes2020https://conductscience.org/library/papers/32843568PubMed
611986199The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.Blood2002https://conductscience.org/library/papers/11986199PubMed
715638990Stability of Ala 125 recombinant human interleukin-2 in solution.J Pharm Pharmacol2005https://conductscience.org/library/papers/15638990PubMed
833571932Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy.Cytokine2021https://conductscience.org/library/papers/33571932PubMed
927578889Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions.Protein Eng Des Sel2016https://conductscience.org/library/papers/27578889PubMed
1033993908Changes and significance of Treg and Th17 in adult patients with primary membranous nephropathy.Clin Nephrol2021https://conductscience.org/library/papers/33993908PubMed
1123446139CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.Arthritis Res Ther2013https://conductscience.org/library/papers/23446139PubMed
1239232245The pathogenesis of IgA nephropathy and implications for treatment.Nat Rev Nephrol2025https://conductscience.org/library/papers/39232245PubMed
1335484394Membranous nephropathy: new pathogenic mechanisms and their clinical implications.Nat Rev Nephrol2022https://conductscience.org/library/papers/35484394PubMed
1412391178Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.J Immunol2002https://conductscience.org/library/papers/12391178PubMed
1531811270Treg cell-based therapies: challenges and perspectives.Nat Rev Immunol2020https://conductscience.org/library/papers/31811270PubMed
1612925844CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.Nat Med2003https://conductscience.org/library/papers/12925844PubMed
1737741949"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".Genes Immun2023https://conductscience.org/library/papers/37741949PubMed
1815184499In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.J Exp Med2004https://conductscience.org/library/papers/15184499PubMed
1936334986Autoimmunity in Anti-Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy.Am J Kidney Dis2023https://conductscience.org/library/papers/36334986PubMed
2015184500CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.J Exp Med2004https://conductscience.org/library/papers/15184500PubMed

See all 46 referencesDownload CSV of references

Genes29

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
FCGR1A2209PubTator's text mininghttps://conductscience.org/library/genes/2209NCBI Gene
FCGRT2217PubTator's text mininghttps://conductscience.org/library/genes/2217NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
IL2RB3560PubTator's text mininghttps://conductscience.org/library/genes/3560NCBI Gene
IL2RG3561PubTator's text mininghttps://conductscience.org/library/genes/3561NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
IL7R3575PubTator's text mininghttps://conductscience.org/library/genes/3575NCBI Gene

See all 29 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41799211

GET https://conductscience.org/api/papers/v1/41799211/references?page=2